4//SEC Filing
Yanni Barbara 4
Accession 0001062993-22-012385
CIK 0001205922other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 4:39 PM ET
Size
10.6 KB
Accession
0001062993-22-012385
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
Yanni Barbara
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-12+53,254→ 53,254 totalExercise: $1.12From: 2023-05-12→ Common Stock (53,254 underlying)
Holdings
- 6,396
Stock Option (Right to Buy)
Exercise: $13.60Exp: 2027-09-15→ Common Stock (6,396 underlying) - 7,718
Stock Option (Right to Buy)
Exercise: $7.78From: 2020-05-15→ Common Stock (7,718 underlying) - 15,679
Stock Option (Right to Buy)
Exercise: $3.95From: 2021-05-14→ Common Stock (15,679 underlying) - 28,586
Stock Option (Right to Buy)
Exercise: $2.15From: 2022-05-11→ Common Stock (28,586 underlying)
Footnotes (5)
- [F1]Exercisable in full as of the date of this report.
- [F2]This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
- [F3]This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
- [F4]This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
- [F5]This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.
Issuer
VACCINEX, INC.
CIK 0001205922
Entity typeother
Related Parties
1- filerCIK 0001610561
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 4:39 PM ET
- Size
- 10.6 KB